Trial Information
Outcomes of a DIEP Flap Program
Inclusion Criteria:
- Intraductal carcinoma
- Lobular carcinoma
- Infiltrating ductal carcinoma
- Paget's disease
- BRCA positive
Exclusion Criteria:
- Inflammatory carcinoma of the breast
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Retrospective
Outcome Measure:
reconstruction rate
Outcome Time Frame:
6 years
Safety Issue:
Yes
Principal Investigator
Bernard T Lee, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Beth Israel Deaconess Medical Center
Authority:
United States: Institutional Review Board
Study ID:
2007-P-000232/1
NCT ID:
NCT00543907
Start Date:
September 2007
Completion Date:
August 2013
Related Keywords:
- Breast Cancer
- breast reconstruction
- DIEP flap
- Breast Neoplasms
Name | Location |
Beth Israel Deaconess Medical Center |
Boston, Massachusetts 02215 |